ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,820Medicare Part D Prescriptions Filled, Including Refills

Rank: 449 out of 1456

$459K Total Retail Price of All Prescriptions

Rank: 496 out of 1456

202 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 202 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

18% of this provider’s 202 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 8,394 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
DONEPEZIL HCL 323 318 1 29
LISINOPRIL 283 274 2 3
AMLODIPINE BESYLATE 264 264 3 1
LANTUS 261 240 4 50
FUROSEMIDE 244 237 5 7
TRAMADOL HCL 241 240 6 17
HYDROCODONE-ACETAMINOPHEN 217 204 S3 7 6
SYNTHROID 217 212 7 37
METOPROLOL TARTRATE 210 209 9 12
NAMENDA 207 207 10 38
MIRTAZAPINE 203 202 11 65
OMEPRAZOLE 191 191 12 5
NOVOLIN R 168 159 13 133
PRAVASTATIN SODIUM 158 153 14 9
DIVALPROEX SODIUM 154 154 15 108
GABAPENTIN 146 136 16 13
COUMADIN 130 130 17 225
RANITIDINE HCL 130 120 17 27
CARAFATE 117 95 19 321
LIDODERM 114 114 20 166
POTASSIUM CHLORIDE 104 102 21 15
CARVEDILOL 98 90 22 20
FAMOTIDINE 94 94 23 45
NITROGLYCERIN PATCH 89 89 24 178
SERTRALINE HCL 88 88 25 25
ESCITALOPRAM OXALATE 82 80 26 74
RISPERIDONE 82 82 26 72
CITALOPRAM HBR 80 80 28 22
MUPIROCIN 77 71 29 224
HYDROCHLOROTHIAZIDE 74 65 30 10
ALBUTEROL SULFATE 71 71 31 136
IPRATROPIUM BROMIDE 69 69 32 184
TRANSDERM-SCOP 68 68 33 348
ISOSORBIDE MONONITRATE ER 68 68 33 60
HYDRALAZINE HCL 68 65 33 48
CYMBALTA 61 61 36 52
QUETIAPINE FUMARATE 61 61 36 78
CLONIDINE HCL 57 54 38 39
AMIODARONE HCL 56 56 39 228
LEVETIRACETAM 54 52 40 97
METOPROLOL SUCCINATE 53 53 41 19
LEVOTHYROXINE SODIUM 51 51 42 4
FENTANYL 51 51 S2 42 114
ABILIFY 50 45 44 244
OXYCONTIN 50 47 S2 44 235
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.